2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [ J ]. Int J Cancer,2010, 127 ( 12 ) : 2893-2917.
3Li K, Zhang YL, Dan Z, et al. Risk factors for the gastric cancer:A case- control study in Tibet[J]. Dig Liver Dis, 2009, 1 ( 1 ):78-79.
4Kim N, Jung HC.The role of serum pepsinogen in the detection of gastric cancer[ J ].Gut Liver, 2010,4(3 ): 307 -311.
5Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice [J ]. Lancet 0ncol,2008,9 (3):279- 287.
6Mande| JS, Church TR, Bond JH, et al. The effect of fecal occuh-blood screening on the incidence of colorectal caneer[J ]. N Engl J Med, 2000, 343(22):1603-1607.
7Bond JH. FOBT is not an effective way to screen for gastric cancer[J]. Dig Liver Dis, 2007, 39(4 ):327-328.
8熊立凡;刘玉成.临床检验基础[M]北京:人民卫生出版社,2010207.
9叶应妩;王毓三;申子瑜.全国临床检验操作规程[M]南京:东南大学出版社,2006310.
10Young GP,St John D J,Winawer S J. Choice of fecal occult blood tests for colorectal cancer screening.Recommendations based on performance characteristics in population studies:a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report[J].American Journal of Gastroenterology,2002,(10):2499-2507.
